SynthesisFrontiers in medicine2026
Frailty in peritoneal dialysis patients: a scoping review.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To conduct a scoping review of research on frailty in peritoneal dialysis (PD) patients, providing a basis for future studies. Methods: Following the scoping review reporting guidelines, a systematic search of domestic and international databases was performed for studies on frailty in PD patients from inception to April 10, 2026. Two researchers independently screened the literature and extracted data. Results: A total of 29 studies were finally included, of which 28 reported the incidence of frailty in PD patients, ranging from 7.3% to 83%, showing considerable variation across different studies and assessment tools. Frailty was influenced by multidimensional factors, including sociodemographic characteristics, disease-related variables, physical function and body composition indicators, and psychological-behavioral factors. The main assessment tools used were the Fried Frailty Phenotype Scale and the Clinical Frailty Scale (CFS). However, there is a lack of assessment tools specifically tailored to the disease characteristics of PD patients. Conclusion: The prevalence of frailty in PD patients varies considerably and is affected by multiple factors. Existing assessment tools require further optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.